MD Anderson Cancer Center - India
Author Profile
Early Academic Pursuits
Dr. Zahid Rafiq Bhat embarked on his academic journey in the field of pharmaceutical sciences from the Govt. Higher Secondary School in Awantipora, India. He achieved outstanding academic performance throughout his educational pursuits, evident from his consistent first-class scores. Zahid pursued his B. Pharm (Bachelor's in Pharmaceutical Sciences) from the Department of Pharmaceutical Sciences at the University of Kashmir, Srinagar, where he continued to excel academically. His early academic foundations provided him with a strong base, setting the stage for his subsequent advanced studies in pharmacology and toxicology.
Professional Endeavors
With a strong academic foundation, Dr. Zahid continued to make significant strides in his professional career. He pursued and completed his M.S. (Pharm) in Pharmacology and Toxicology from the National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, Mohali, Punjab, India. His research during this period was funded by the Department of Pharmaceuticals and the Ministry of Chemicals and Fertilizers, India. Subsequently, he went on to earn his Ph.D. in Pharmacology and Toxicology from the same esteemed institution. Throughout his professional journey, Zahid has garnered extensive research experience, worked as an assistant professor, guided research scholars, and contributed significantly to the fields of pharmacology, toxicology, and epigenetics.
Contributions and Research Focus
Dr. Zahid Rafiq Bhat's research primarily revolves around the intricate realms of pharmacology and toxicology, with a specific focus on epigenetics. His groundbreaking thesis titled “Lysine Methyl Transferase (NSD1) as Epigenetic Target in Cancer” underscores his commitment to exploring innovative approaches to cancer treatment. His expertise spans across molecular biology, nanotechnology, translational research, and bioinformatics. Zahid's contributions to scientific literature are evident from his numerous publications in reputable international journals and book chapters. His research endeavors encompass a wide range of topics, including cancer, diabetes, obesity, and polycystic ovary syndrome (PCOS), among others.
Accolades and Recognition
Dr. Zahid's exemplary academic and professional achievements have been acknowledged through various scholarships and awards. He has been the recipient of prestigious fellowships such as the Department of Scientific Technology (DST)-Science and Engineering Research Board (SERB) Junior Research Fellowship and the Indian Council of Medical Research- Senior Research Fellowship. His remarkable performance in national-level examinations, including GPAT and NIPER JEE, further underscores his academic prowess and dedication to the field.
Impact and Influence
Dr. Zahid Rafiq Bhat's research has had a profound impact on the scientific community, particularly in the fields of pharmacology, toxicology, and epigenetics. His publications in renowned international journals have contributed valuable insights and advanced the understanding of complex biological processes and potential therapeutic interventions. Furthermore, his expertise in guiding research scholars, conducting workshops, and participating in conferences has fostered knowledge dissemination and collaboration within the scientific community.
Legacy and Future Contributions
As a dedicated researcher and educator, Dr. Zahid continues to inspire and mentor the next generation of scientists. His legacy is characterized by a relentless pursuit of knowledge, innovation, and excellence in research. Moving forward, Zahid Rafiq Bhat aims to expand his research endeavors, collaborate with global experts, and develop novel therapeutic strategies for addressing complex diseases. His future contributions are poised to further enhance our understanding of disease mechanisms, facilitate the development of innovative treatments, and shape the future of pharmacology and toxicology.
In summary, Dr. Zahid Rafiq Bhat's journey is a testament to his unwavering commitment to academic and research excellence. His early academic pursuits, professional endeavors, significant contributions to research, accolades, and future aspirations collectively underscore his remarkable achievements and invaluable contributions to the scientific community.
Notable Publication
- MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylation (27), 2020
- Synthesis and evaluation of new 1, 2, 4-oxadiazole based trans-acrylic acid derivatives as potential PPAR-alpha/gamma dual agonist (25), 2020
- Role of autophagy and histone deacetylases in diabetic nephropathy: Current status and future perspectives (18), 2016
- Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment (12), 2021
- In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor … (1), 2022